Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAD1 | O60671 | 1/20 | 0.50 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.50 |
| ▸ | SENP2 | Q9HC62 | 5/20 | 0.39 |
| ▸ | SENP1 | Q9P0U3 | 5/20 | 0.39 |
| ▸ | SENP3 | Q9H4L4 | 4/20 | 0.39 |
| ▸ | SUMO2 | P61956 | 3/20 | 0.39 |
| ▸ | SUMO1 | P63165 | 3/20 | 0.39 |
| ▸ | SENP7 | Q9BQF6 | 3/20 | 0.39 |
| ▸ | RAD51 | Q06609 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | USP2 | O75604 | 2/20 | 0.39 |
| ▸ | LTA | P01374 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2834143 | 0.99 | RAD1 (0.51) | RAD1P2RY6SENP2SENP1SENP3 | |
| SCHEMBL29015815 | 0.85 | SENP2 (0.40) | RAD1P2RY6SENP2SENP1SENP3 | |
| SCHEMBL29978315 | 0.85 | RAD1 (0.51) | RAD1P2RY6SENP2SENP1SENP3 | |
| SCHEMBL5364759 | 0.85 | RAD1 (0.51) | RAD1P2RY6SENP2SENP1SENP3 | |
| SCHEMBL344713 | 0.85 | RAD1 (0.51) | RAD1P2RY6SENP2SENP1SENP3 | |
| SCHEMBL1976079 | 0.81 | RAD1 (0.42) | RAD1P2RY6SENP2SENP1SENP3 | |
| SCHEMBL6533768 | 0.80 | RAD51 (0.44) | RAD1P2RY6SENP2SENP1SENP3 | |
| SCHEMBL6533773 | 0.80 | RAD51 (0.44) | RAD1P2RY6SENP2SENP1SENP3 | |
| SCHEMBL10622332 | 0.80 | APEX1 (0.47) | RAD1P2RY6SENP2SENP1SENP3 | |
| SCHEMBL9358944 | 0.76 | RAD1 (0.55) | RAD1P2RY6SENP2SENP1SENP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230065890-A1 | ADAPTORS FOR NUCLEIC ACID CONSTRUCTS IN TRANSMEMBRANE SEQUENCING | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2023-03-02 | — | — | US | disclosed |
| US-20220177937-A1 | POLYNUCLEOTIDE SYNTHESIS METHOD, KIT AND SYSTEM | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2022-06-09 | — | — | US | disclosed |
| US-11352664-B2 | Adaptors for nucleic acid constructs in transmembrane sequencing | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2022-06-07 | — | — | US | disclosed |
| US-20220090192-A1 | METHOD OF NANOPORE SEQUENCING OF CONCATENATED NUCLEIC ACIDS | OXFORD NANOPORE TECHNOLOGIES LTD. (GB) | 2022-03-24 | — | — | US | disclosed |
| US-20190376132-A1 | ADAPTORS FOR NUCLEIC ACID CONSTRUCTS IN TRANSMEMBRANE SEQUENCING | OXFORD NANOPORE TECHNOLOGIES LTD. (GB) | 2019-12-12 | — | — | US | disclosed |
| US-20180291440-A1 | ADAPTORS FOR NUCLEIC ACID CONSTRUCTS IN TRANSMEMBRANE SEQUENCING | OXFORD NANOPORE TECHNOLOGIES LTD. (GB) | 2018-10-11 | — | — | US | disclosed |
| US-20170321266-A1 | ADAPTORS FOR NUCLEIC ACID CONSTRUCTS IN TRANSMEMBRANE SEQUENCING | OXFORD NANOPORE TECHNOLOGIES LTD. (GB) | 2017-11-09 | — | — | US | disclosed |
| US-20120100530-A1 | ENZYME MUTANT | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2012-04-26 | — | — | US | disclosed |
| US-20120058468-A1 | ADAPTORS FOR NUCLEIC ACID CONSTRUCTS IN TRANSMEMBRANE SEQUENCING | OXFORD NANOPORE TECHNOLGIES LIMITED (GB) | 2012-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11352664-B2 | Adaptors for nucleic acid constructs in transmembrane sequencing | MTREX, PHAX, TARBP1 | RAD1 2402/4885P2RY6 1477/4885SENP2 3454/4885 |
| US-20230065890-A1 | ADAPTORS FOR NUCLEIC ACID CONSTRUCTS IN TRANSMEMBRANE SEQUENCING | MTREX, PHAX, TARBP1 | RAD1 2402/4885P2RY6 1477/4885SENP2 3454/4885 |
| US-20120058468-A1 | ADAPTORS FOR NUCLEIC ACID CONSTRUCTS IN TRANSMEMBRANE SEQUENCING | MTREX, PHAX, TARBP1 | RAD1 2402/4885P2RY6 1477/4885SENP2 3454/4885 |
| US-20120100530-A1 | ENZYME MUTANT | UNG, RNGTT, FEN1 | RAD1 1848/4885P2RY6 3827/4885SENP2 421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.